Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen George Dilly currently holds 727,053 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen George Dilly has been a net seller of AIMT stock. They have purchased $190.3K and sold $21.8M worth of shares.
Stephen George Dilly's most recent insider trade was on Nov 11, 2025, when they sold 50,000 shares at $1.85 per share.
Stephen George Dilly serves as Executive at Aimmune Therapeutics, Inc. (AIMT). They have executed 74 insider transactions totaling $22.0M over their tenure at the company.
Stephen George Dilly holds the position of Executive at Aimmune Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Stephen George Dilly has shown a selling trading pattern, with $190.3K in total purchases and $21.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen George Dilly was on Oct 23, 2017, when they sold $2.5M worth of AIMT shares. This transaction involved 75,468 shares at $33.23 per share.
Stephen George Dilly currently owns 727,053 shares of Aimmune Therapeutics, Inc. (AIMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen George Dilly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen George Dilly has 74 Form 4 filings on record as an insider at Aimmune Therapeutics, Inc..
Set alerts for Stephen George Dilly and 40,000+ other insiders.